# Wake Forest Baptist Health- Blood Bank Hospital – FDA Inspection, Dec 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/wake-forest-baptist-health-blood-bank-hospital/a4970092-8df2-4da0-8190-9c034ec2093a
Source feed: FDA_Inspections

> FDA inspection 1036762 of Wake Forest Baptist Health- Blood Bank Hospital, December 14, 2017. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036762
- Company Name: Wake Forest Baptist Health- Blood Bank Hospital
- Inspection Date: 2017-12-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1249368 - 2024-09-11
- FDA Inspection 1164773 - 2022-03-11
- FDA Inspection 966437 - 2016-04-20
- FDA Inspection 887836 - 2014-07-17
- FDA Inspection 787067 - 2012-06-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/doretha-m-wilson/85db7b75-2b34-4400-9c0d-9bde1235abf3)

Company: https://www.keypedia.com/companies/wake-forest-baptist-health-blood-bank-hospital/71baa1f0-434d-4c6f-baae-7cce9c71be52

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d